Fleer R, Brendel M
Chem Biol Interact. 1981 Oct;37(1-2):123-40. doi: 10.1016/0009-2797(81)90170-8.
Treatment of yeast cells with 4-hydroperoxy-cyclophosphamide (4-OOH-CP), the chemically activated form of cyclophosphamide, results in cell killing, induction of DNA interstrand cross-links and DNA fragmentation. Toxicity of 4-OOH-CP is greatly influenced by the cell's capacity of DNA dark-repair: genetic blocking of non-epistatic pathways of DNA repair results in an increase of sensitivity of several orders of magnitude. DNa primary lesions have been measured using a haploid, excision deficient, dTMP-uptaking mutant of S. cerevisiae. In this strain, a significant extent of DNA cross-linking can already be observed at a survival of 88%. At a concentration of 100 nmol/ml 4-OOH-CP, renaturability of DNA increases up to 12 h of drug exposure and drops to lower values upon further incubation. In contrast to the time course of renaturability, DNA double-strand breakage is seen at later stages of drug treatment and continuously increases as a function of incubation time. Whereas inactivation of cells and induction of strand breakage continue upon postincubation of cells, comparable effects are much less pronounced for DNA renaturability.
用环磷酰胺的化学活化形式4-氢过氧环磷酰胺(4-OOH-CP)处理酵母细胞,会导致细胞死亡、诱导DNA链间交联和DNA片段化。4-OOH-CP的毒性受细胞DNA暗修复能力的极大影响:DNA修复非上位性途径的基因阻断会导致敏感性增加几个数量级。已使用酿酒酵母的单倍体、切除缺陷、摄取dTMP的突变体测量了DNA初级损伤。在该菌株中,在存活率为88%时就已观察到相当程度的DNA交联。在100 nmol/ml 4-OOH-CP浓度下,DNA的复性能力在药物暴露12小时内增加,进一步孵育后降至较低值。与复性能力的时间进程相反,DNA双链断裂在药物处理后期出现,并随孵育时间持续增加。细胞孵育后细胞失活和链断裂诱导仍会继续,但DNA复性能力的类似效应则不那么明显。